| 13 Mars 2018
9 March 2018 - CAPE TOWN: The World Health Organization  (WHO) has launched new guidance on the role tobacco product regulation  can play to reduce tobacco demand, save lives and raise revenues for  health services to treat tobacco-related disease, in the context of  comprehensive tobacco control. A new guide, “Tobacco product regulation: Building laboratory testing  capacity”, and a collection of country approaches to regulation of  menthol, presented in the publication titled “Case studies for  regulatory approaches to tobacco products – Menthol in tobacco products”  have been launched at the 2018 World Conference on Tobacco or Health in  Cape Town, South Africa.
 
 Many countries have developed advanced policies to reduce the demand for  tobacco, which kills over 7 million people annually, but governments  can do much more to implement regulations to control tobacco use,  especially by exploiting tobacco product regulation.
 
 Dr Douglas Bettcher, WHO’s Director of the Department for the Prevention  and Control of Noncommunicable diseases (NCDs), said “The WHO Framework  Convention on Tobacco Control (WHO FCTC), a global treaty established  under the auspices of the WHO to combat the tobacco epidemic, has played  a critical role in tobacco control. The launch of these important  publications will further aid the implementation of Articles 9 and 10 of  the WHO FCTC, contributing to building tobacco product regulation  capacity in WHO Member States”.
 
 He further said “Tobacco product regulation is an under-utilized tool  which has a critical role to play in reducing tobacco use. The tobacco  industry has enjoyed years of little or no regulation, mainly due to the  complexity of tobacco product regulation and lack of appropriate  guidance in this area. These new tools provide a useful resource to  countries to either introduce or improve existing tobacco product  regulation provisions and end the tobacco industry ‘reign’.”
 
 “Only a handful of countries currently regulate the contents, design  features and emissions of tobacco products,” says Dr Bettcher. “This  means that tobacco products are one of the few openly available consumer  products that are virtually unregulated in terms of contents, design  features and emissions.”
 
 Most countries hesitate to implement policies, due in part to the highly  technical nature of such policy interventions and the difficulties in  translating science into regulation, explains Dr Vinayak Prasad, who  leads WHO’s Tobacco Free Initiative.
 
 “Failure to regulate represents a missed opportunity as tobacco product  regulation, in the context of comprehensive control, is a valuable tool  that complements other tried and tested tobacco control interventions,  such as raising taxes, and ensuring smoke-free environments,” adds Dr  Prasad.
 
 “Tobacco product regulation: Building laboratory testing capacity”  provides practical, stepwise approaches to implementing tobacco testing.  Such guidance is relevant to a wide range of countries in various  settings, including those with inadequate resources to establish a  testing facility. This laboratory guide is a useful resource for  countries, and provides regulators and policymakers with comprehensible  information on how to test tobacco products, what products to test, and  how to use testing data in a meaningful way to support regulation.
 
 Further, it provides a step-by-step guide to developing a testing  laboratory, using an existing internal laboratory, contracting an  external laboratory, and making use of the available support mechanisms  both within WHO and externally. This calls for country prioritization  and commitment of resources to tobacco product regulation, as the guide  equips regulators with the necessary tools to strengthen tobacco  regulation capacity, especially in relation to Article 9 of the WHO  FCTC.
 
 The publication “Case studies for regulatory approaches to tobacco  products – Menthol in tobacco products” complements the 2016 advisory  note on menthol published by the WHO Study Group on Tobacco Product  Regulation, which set out the available evidence on prevalence and  health effects of menthol in tobacco products, as well as evidence-based  conclusions and recommendations for policy-makers and regulators on  menthol in its various forms.
 
 The case studies provide practical guidance and policy options to  countries about effective regulatory strategies in tobacco product  regulation. This includes lessons learned and challenges encountered in  developing and implementing menthol related regulation. To date,  regulators have adopted multiple approaches to restricting the use of  menthol. These include a ban in some product categories, a total ban on  the use of all flavours and a ban on all products with a perceived  menthol flavour. This publication also provides useful information on  the merits and drawbacks of various regulatory approaches.
http://www.who.int/tobacco/communications/news/guidance-tobacco-product-regulation/en/